J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M200357-JLR200 on November 4, 2002

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200357-JLR200v1
44/2/424    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yan, H.
Right arrow Articles by Lau, D. C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yan, H.
Right arrow Articles by Lau, D. C. W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 44, 424-429, February 2003
Copyright © 2003 by Lipid Research, Inc.

Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells

Hongyun Yan, Abdenaim Kermouni, Mohammed Abdel-Hafez and David C. W. Lau1

Julia McFarlane Diabetes Research Centre, Departments of Medicine, Biochemistry and Molecular Biology, The University of Calgary, Calgary, AB, T2N 4N1, Canada

1 To whom correspondence should be addressed. e-mail: dcwlau{at}ucalgary.ca

Cyclooxygenase (COX) catalyses the rate-limiting step of prostanoid biosynthesis. Two COX isoforms have been identified, COX-1, the constitutive form, and COX-2, the inducible form. While COX-2 has been implicated in body fat regulation, the underlying cellular mechanism remains to be elucidated. The present study was undertaken to examine the potential role of COX in modulating adipogenesis and to dissect the relative contribution of the two isoenzymes in this process. COX-2 was found to be expressed in undifferentiated 3T3-L1 cells and down-regulated during differentiation, whereas the cellular level of COX-1 remained relatively constant. Abrogating the activity of either of these two isoenzymes by selective COX inhibitors accelerated cellular differentiation, suggesting that both COX isoenzymes negatively influenced differentiation. Tumor necrosis factor-{alpha} (TNF{alpha}) significantly up-regulated COX-2 expression (~2-fold) in differentiating 3T3-L1 cells, whereas similar effect was not observed with COX-1 expression. Abrogating the induced COX-2 activity reversed the TNF{alpha}-induced inhibition of differentiation by ~70%, implying a role for COX-2 in mediating TNF{alpha} signaling.

Hence, both COX isoforms were involved in the negative modulation of adipocyte differentiation. COX-2 appeared to be the main isoform mediating at least part of the negative effects of TNF{alpha}.

Abbreviations: c/EBP{alpha}, aP2, adipocyte fatty acid-binding protein; CCAAT/enhancer-binding protein {alpha}; COX, cyclooxygenase; DD, day of differentiation; Dex, dexamethasone; DMEM, Dulbecco's modified Eagle's medium; GLUT4, glucose transporter-4; GPDH, glycerol-3-phosphate dehydrogenase; HRP, horseradish peroxidase; MIX, 1-methyl-3-isobutylxanthine; PG, prostaglandin; PPAR{gamma}2, peroxisome-proliferator-activated receptor {gamma} 2; TNF{alpha}, tumor necrosis factor-{alpha}

Supplementary key words tumor necrosis factor-{alpha} • prostaglandin • prostanoid biosynthesis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
R. E. Duncan, E. Sarkadi-Nagy, K. Jaworski, M. Ahmadian, and H. S. Sul
Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA)
J. Biol. Chem., September 12, 2008; 283(37): 25428 - 25436.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
M. Dragunow, R. Cameron, P. Narayan, and S. O'Carroll
Image-Based High-Throughput Quantification of Cellular Fat Accumulation
J Biomol Screen, October 1, 2007; 12(7): 999 - 1005.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
J. Tirard, J. Gout, A. M. Lefrancois-Martinez, A. Martinez, M. Begeot, and D. Naville
A Novel Inhibitory Protein in Adipose Tissue, the Aldo-Keto Reductase AKR1B7: Its Role in Adipogenesis
Endocrinology, May 1, 2007; 148(5): 1996 - 2005.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. Martin-Venegas, S. Roig-Perez, R. Ferrer, and J. J. Moreno
Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation
J. Lipid Res., July 1, 2006; 47(7): 1416 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
R. K. Petersen, C. Jorgensen, A. C. Rustan, L. Froyland, K. Muller-Decker, G. Furstenberger, R. K. Berge, K. Kristiansen, and L. Madsen
Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases
J. Lipid Res., December 1, 2003; 44(12): 2320 - 2330.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Fajas, S. Miard, M. R. Briggs, and J. Auwerx
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase
J. Lipid Res., September 1, 2003; 44(9): 1652 - 1659.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.